These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16651863)

  • 41. Elimination of acquired factor VIII antibodies by extracorporal antibody-based immunoadsorption (Ig-Therasorb).
    Knöbl P; Derfler K; Korninger L; Kapiotis S; Jäger U; Maier-Dobersberger T; Hörl W; Lechner K; Pabinger I
    Thromb Haemost; 1995 Oct; 74(4):1035-8. PubMed ID: 8560408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Development of an enzyme immunoassay for determination of factor VIII antigens].
    Schössler W; Stepanauskas M; Dittrich C; Heine H
    Acta Biol Med Ger; 1982; 41(2-3):263-6. PubMed ID: 6810603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolation of human antibodies to factor VIII.
    Lavergne JM; Meyer D; Koutts J; Larrieu MJ
    Br J Haematol; 1978 Dec; 40(4):631-41. PubMed ID: 365219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of VWF in the immunogenicity of FVIII.
    Lacroix-Desmazes S; Repessé Y; Kaveri SV; Dasgupta S
    Thromb Res; 2008; 122 Suppl 2():S3-6. PubMed ID: 18549909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular studies of rheumatoid factor using pseudobioaffinity membrane chromatography.
    Kamalanathan AS; Vijayalakshmi MA
    J Mol Recognit; 2009; 22(2):146-53. PubMed ID: 18828180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients.
    Mahendra A; Peyron I; Thaunat O; Dollinger C; Gilardin L; Sharma M; Wootla B; Rao DN; Padiolleau-Lefevre S; Boquet D; More A; Varadarajan N; Kaveri SV; Legendre C; Lacroix-Desmazes S
    J Immunol; 2016 May; 196(10):4075-81. PubMed ID: 27067006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibodies to factor VIII. 3. Characterization of the immune response to iso- and heteroantigens in hemophilia A.
    Allain JP; Vedrenne J; Frommel D
    Pathol Biol (Paris); 1973 Nov; 21():Suppl:76-9. PubMed ID: 4128454
    [No Abstract]   [Full Text] [Related]  

  • 49. Catalytic antibodies: balancing between Dr. Jekyll and Mr. Hyde.
    Belogurov A; Kozyr A; Ponomarenko N; Gabibov A
    Bioessays; 2009 Nov; 31(11):1161-71. PubMed ID: 19795406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunological aspects of inhibitor development.
    Reding MT
    Haemophilia; 2006 Dec; 12 Suppl 6():30-5; discussion 35-6. PubMed ID: 17123391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoglobulin A with protease activity secreted in human milk activates PAR-2 receptors, of intestinal epithelial cells HT-29, and promotes beta-defensin-2 expression.
    Barrera GJ; Portillo R; Mijares A; Rocafull MA; del Castillo JR; Thomas LE
    Immunol Lett; 2009 Mar; 123(1):52-9. PubMed ID: 19428552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure and function of factor VIII procoagulant protein.
    Fulcher CA; Zimmerman TS
    Prog Clin Biol Res; 1984; 150():57-71. PubMed ID: 6431442
    [No Abstract]   [Full Text] [Related]  

  • 53. Successful rituximab therapy of acquired factor VIII inhibitor in a patient with rheumatoid arthritis.
    Oliveira B; Arkfeld DG; Weitz IC; Shinada S; Ehresmann G
    J Clin Rheumatol; 2007 Apr; 13(2):89-91. PubMed ID: 17414538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel therapies for immune tolerance in haemophilia A.
    Collins PW
    Haemophilia; 2006 Dec; 12 Suppl 6():94-100; discussion 100-1. PubMed ID: 17123401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Catalytic autoantibodies in clinical autoimmunity and modern medicine.
    Gabibov AG; Ponomarenko NA; Tretyak EB; Paltsev MA; Suchkov SV
    Autoimmun Rev; 2006 May; 5(5):324-30. PubMed ID: 16782557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies.
    Kosmoliaptsis V; Bradley JA; Peacock S; Chaudhry AN; Taylor CJ
    Transplantation; 2009 Mar; 87(6):813-20. PubMed ID: 19300182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acquired haemophilia. A case report.
    Siow BL; Nadarajah K; Jayaratnam FJ
    Singapore Med J; 1982 Dec; 23(6):328-30. PubMed ID: 6820189
    [No Abstract]   [Full Text] [Related]  

  • 58. Catalytic antibodies and severe sepsis.
    Lacroix-Desmazes S; Mallet V; Wootla B; Kaveri SV
    Discov Med; 2005 Apr; 5(26):209-12. PubMed ID: 20704912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of immune complexes of idiotypic catalytic and anti-idiotypic inhibitory antibodies in plasma of type 1 diabetic subjects.
    Pagetta A; Tramentozzi E; Corbetti L; Frasson M; Brunati AM; Finotti P
    Mol Immunol; 2007 Apr; 44(11):2870-83. PubMed ID: 17298847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitor development.
    Astermark J; Lacroix-Desmazes S; Reding MT
    Haemophilia; 2008 Jul; 14 Suppl 3():36-42. PubMed ID: 18510520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.